Relation of Muscle Indices with Metabolic Parameters and C-Peptide in Type 2 Diabetes Mellitus

J Coll Physicians Surg Pak. 2017 Nov;27(11):673-677.

Abstract

Objective: To assess the relation between bioimpedance measurements and metabolic parameters and C-peptide in patient with type 2 diabetes mellitus (DM).

Study design: Cross-sectional study.

Place and duration of study: Kartal Dr Lutfi Kirdar Training and Research Hospital, Pendik Kaynarca Diabetes Center, Exercise and Metabolism Unit, between January and March 2015.

Methodology: Patients with DM, aged less than 65 years, were assessed for bioimpedance analysis, fasting plasma glucose (FPG), HbA1c, C-peptide levels, triglyceride levels, LDL-cholesterol, and HDL-cholesterol levels. Skeletal muscle index, total muscle index, skeletal muscle percentage, and total muscle percentage were used for muscle-related analyses. Mann-Whitney U-test or independent t-test were used to compare differences between two independent groups. Pearson correlation test or Spearman correlation test were used to find out correlation between variables.

Results: Atotal of 359 DM patients were enrolled in the study. Mean age was 51.6 ±8.0 years, and 278 (77.7%) of the participants were females. After adjusting age and gender variables, there was no relation between muscle-related measurements and FPG, triglyceride, LDL-cholesterol (p>0.05). However, there was muscle-related indexes (MRI) positively correlation with C-peptide and inversely associated with HDL-cholesterol (p<0.05).

Conclusion: Muscle-related indices positively correlated with C-peptide, which showed endogenous insulin reserve.

MeSH terms

  • Adult
  • Blood Glucose / analysis
  • Body Mass Index*
  • C-Peptide / blood*
  • C-Peptide / metabolism
  • Cholesterol, HDL / blood
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / metabolism*
  • Female
  • Humans
  • Male
  • Metabolic Syndrome
  • Middle Aged
  • Muscles / metabolism*
  • Obesity, Abdominal / epidemiology*
  • Sarcopenia / complications
  • Sarcopenia / epidemiology
  • Young Adult

Substances

  • Blood Glucose
  • C-Peptide
  • Cholesterol, HDL